Madrigal Pharmaceuticals, Inc. company logo
Madrigal Pharmaceuticals, Inc. logo

Madrigal Pharmaceuticals, Inc. (MDGL) Cash From Investing

Annual CFI

-$274.39M$228.13M+45.40%

Summary

Current Value
As of today, MDGL annual cash from investing is -$274.39M, up +45.40% on
Historical Performance
MDGL annual cash from investing is down -5328.01% over the past 3 years, and down -993.56% over the past 5 years
All-Time High Comparison
MDGL annual cash from investing is currently -232.76% below its historical high of $206.69M set on
3-Year Low Comparison
MDGL annual cash from investing is +45.40% above its 3-year low of -$502.52M reached on
Sector Comparison
MDGL annual cash from investing is higher than 9.94% of companies in Healthcare sector

Cash From Investing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

MDGL Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Investing-$274.39M+45.4%-5328.0%-993.6%-1403.6%
Quarterly Cash From Investing-$207.00M-2.3%-417.8%-318.5%-1463.9%
TTM Cash From Investing-$43.21M+92.7%-127.7%-132.2%-1760.9%
Price$493.90+62.6%+64.6%+340.2%+113.8%
Annual Cash From Operations-$455.57M-40.5%-147.7%-994.5%-1599.3%
Annual Cash From Financing$735.06M+23.5%+329.3%+10000.0%+10000.0%
Annual CAPEX$6.46M+336.9%+2991.9%+3657.0%+1323.3%
Annual Free Cash Flow-$462.03M-41.9%-150.9%-1005.5%-1594.7%
Annual Total Assets$1.04B+62.7%+281.3%+135.8%+2031.0%

Cash From Investing Highs

MDGL Annual Cash From Investing Highs Comparison
PeriodHighDateCurrent
3Y$206.69MN/A-232.8%
5Y$206.69M-232.8%
All$206.69M-232.8%

Cash From Investing Lows

MDGL Annual Cash From Investing Lows Comparison
PeriodLowDateCurrent
3Y-$502.52M+45.4%
5Y-$502.52M+45.4%
All-$502.52M+45.4%

Cash From Investing History

YearValueChange
-$274.39M+45.4%
-$502.52M-343.1%
$206.69M+4,188.7%
-$5.06M-103.2%
$159.78M+420.3%
$30.71M+108.1%
-$380.08M-1,627.1%
-$22.01M-200.1%
$21.99M>+9,900.0%
$0.00+100.0%
-$8.84M+64.2%
YearValueChange
-$24.65M-147.9%
-$9.94M-206.6%
$9.33M+147.1%
-$19.80M-194.1%
$21.05M+188.9%
-$23.69M-319.6%
$10.79M-54.3%
$23.57M-39.8%
$39.18M+189.4%
-$43.81M-8.4%
-$40.40M-

FAQ

  • What is the current annual cash from investing of MDGL?

    As of today, MDGL annual cash from investing is -$274.39M

  • What is 1-year change in MDGL annual cash from investing?

    MDGL annual cash from investing is up +45.40% year-over-year

  • What is 3-year change in MDGL annual cash from investing?

    MDGL annual cash from investing is down -5328.01% over the past 3 years

  • How far is MDGL annual cash from investing from its all-time high?

    MDGL annual cash from investing is currently -232.76% below its historical high of $206.69M set on December 31, 2022

  • How does MDGL annual cash from investing rank versus sector peers?

    MDGL annual cash from investing is higher than 9.94% of companies in Healthcare sector

  • When is MDGL next annual earnings release?

    The next annual earnings release for MDGL is on

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

Data Sources & References

  1. MDGL Official Website www.madrigalpharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1157601/000162828025048559/0001628280-25-048559-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828025007980/0001628280-25-007980-index.htm
  4. MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
  5. MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl